The triple negative breast cancer subtype (HR-/HER2-) is also diagnosed in 18.08% of Black women, compared to 7.90% of non-Hispanic White women, 11.34% of Hispanic women, and 6.99% of other women. Here, ERBB2 is linked to triple-negative breast carcinoma.